Management of Atrial Septal Defects
Closure of an atrial septal defect (ASD) is indicated for patients with right atrial and right ventricular enlargement with or without symptoms to prevent long-term complications. 1, 2
Types of ASDs and Closure Approaches
- Secundum ASDs (most common type) can be closed percutaneously with a device when anatomically suitable 1, 2, 3
- Sinus venosus, coronary sinus, and primum ASDs require surgical closure rather than percutaneous approaches 1, 4
- Small ASDs (<5 mm) without evidence of RV volume overload generally do not require closure unless associated with paradoxical embolism 1, 2
Indications for ASD Closure
- Presence of right atrial and right ventricular enlargement (with or without symptoms) 1
- Prevention of long-term complications including:
- Atrial arrhythmias
- Reduced exercise tolerance
- Hemodynamically significant tricuspid regurgitation
- Right-to-left shunting and embolism during pregnancy
- Congestive heart failure
- Pulmonary vascular disease (develops in 5-10% of affected individuals, mainly females) 1
- Paradoxical embolism 1, 2
- Documented orthodeoxia-platypnea (positional hypoxemia) 1
Contraindications to Closure
- Severe irreversible pulmonary arterial hypertension (PAH) with no evidence of left-to-right shunt (Eisenmenger physiology) 1, 4
Percutaneous Device Closure
- Preferred for secundum ASDs when anatomically suitable 2, 3
- Benefits over surgical closure include:
- FDA-approved devices include:
Surgical Closure
- Indicated for:
- Should be performed by surgeons with training and expertise in congenital heart disease 1, 4
- Surgical approaches include:
- Concomitant Maze procedure may be considered for intermittent or chronic atrial tachyarrhythmias 1
Special Considerations
- Patients with pulmonary hypertension but with net left-to-right shunting may be considered for closure if:
- Pulmonary artery pressure is less than two-thirds systemic levels
- Pulmonary vascular resistance is less than two-thirds systemic vascular resistance
- Patient is responsive to pulmonary vasodilator therapy or test occlusion of the defect 1
- Patients with atrial arrhythmias and ASD should undergo both arrhythmia management and ASD closure 1
- Earlier closure (before age 25) results in better long-term outcomes and lower incidence of atrial arrhythmias 1
Post-Procedure Management
- Monitor for early postoperative symptoms of undue fever, fatigue, vomiting, chest pain, or abdominal pain which may indicate postpericardiotomy syndrome with tamponade 1, 2
- Annual clinical follow-up is recommended for patients with:
- Pulmonary arterial hypertension
- Atrial arrhythmias
- Right or left ventricular dysfunction
- Coexisting valvular or other cardiac lesions 1
- Evaluation for possible device migration, erosion, or other complications 3 months to 1 year after device closure and periodically thereafter 1, 5
- Monitor for potential late complications after device closure including:
Outcomes
- Early mortality is approximately 1% in the absence of PAH or other major comorbidities 1, 2
- Long-term follow-up shows excellent results with decrease or resolution of preoperative symptoms 1, 8
- Closure is associated with improvement in functional class, right ventricular pressure, volumes, and dimensions 2, 8